Minhang Tower
3–5 Floors No. 290 North Zhongshan Road Gongshu District
Hangzhou
China
86 57 1888 26555
https://www.raily.com
Settore/i: Healthcare
Settore: Medical Care Facilities
Impiegati a tempo pieno: 335
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Haishu Fu | Executive Chairman of the Board | 904,96k | N/D | 1975 |
Mr. Jianliang Song | CEO & Executive Director | 644,87k | N/D | 1956 |
Ms. Chunxiu Zhang | Chief Financial Officer | 736,22k | N/D | 1982 |
Mr. Ying Wang | Executive Director | 432,06k | N/D | 1977 |
Mr. Oi Fat Chan | Company Secretary | N/D | N/D | 1978 |
Raily Aesthetic Medicine International Holdings Limited, an investment holding company, provides aesthetic medical services. The company operates through three segments: Aesthetic Medical Services, Consulting Services, and Aesthetic Medical Equipment Products. Its services include aesthetic surgery services, including aesthetic surgical procedures performed on various parts of the face or body; minimally invasive aesthetic services, primarily comprising aesthetic injection procedures; aesthetic dermatology services, such as various aesthetic energy-based procedures; and aesthetic medical management consulting services. The company also offers aesthetic dental services, including orthodontics, and dental implant and whitening; and trades in medical equipment. In addition, it sells surgical implants and aesthetic medical skincare products. The company owns and operates a network of four private for-profit aesthetic medical institutions in Zhejiang and Anhui Province, the People's Republic of China. It serves individual retail clients and aesthetic medical institutions. The company was founded in 2008 and is headquartered in Hangzhou, the People's Republic of China. Raily Aesthetic Medicine International Holdings Limited is a subsidiary of Ruide Consultation Limited.
L'ISS Governance QualityScore di Raily Aesthetic Medicine International Holdings Limited al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.